Delivery Order SPE2DX22D0029-SPE2D825F44RF
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $32,147.19 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply deliveries to support federal medical procurement needs. The work will be performed at AmerisourceBergen's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $24,121.60 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 18, 2025, with completion targeted for August 19, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products to support federal healthcare operations. The work will be performed at AmerisourceBergen's corporate...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $112,938.83 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was made on a competitive basis with no...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $47,519.32 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 8, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $14,900.76 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was awarded through open competition and represents a child award under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The contractor will perform work at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $82,960.80 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical commodities to support federal healthcare operations. The contract is performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,279.88 to AmerisourceBergen Drug Corp on August 25, 2025, with completion targeted for August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare procurement needs. The work will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $139,894.92 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $176,883.07 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. The contract was performed at AmerisourceBergen's corporate office location...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $34,139.94 to AmerisourceBergen Drug Corp on September 1, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, competitively awarded delivery order (Contract No. 4569285368) is being performed at the company's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger indefinite delivery vehicle, this award represents one of numerous...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D825F44RFDelivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $32,142.24 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on September 23, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to supply pharmaceutical products and medical supplies to support federal military and healthcare operations. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and medical supplies—to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract framework, positioning itself as a key supplier ahead of the DLA's planned Pharmaceutical Prime Vendor Global Program Generation V contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.1k | 9/23/25 |